Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.050
-0.030 (-2.78%)
Aug 13, 2025, 4:00 PM - Market closed
Myomo Market Cap
Myomo has a market cap or net worth of $39.69 million as of August 13, 2025. Its market cap has decreased by -71.65% in one year.
Market Cap
39.69M
Enterprise Value
36.64M
1-Year Change
-71.65%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since June 30, 2017, Myomo's market cap has decreased from $66.00M to $39.69M, a decrease of -39.86%. That is a compound annual growth rate of -6.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 66.50M | -65.86% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |